|
GNG10 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.83569999995448E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.66099999999415E-07 |
| Normal-vs-Stage2 |
2.826000E-02 |
| Normal-vs-Stage3 |
1.413520E-02 |
| Normal-vs-Stage4 |
3.437400E-03 |
| Stage1-vs-Stage2 |
8.715800E-01 |
| Stage1-vs-Stage3 |
1.902990E-01 |
| Stage1-vs-Stage4 |
6.715000E-01 |
| Stage2-vs-Stage3 |
5.458000E-01 |
| Stage2-vs-Stage4 |
9.160200E-01 |
| Stage3-vs-Stage4 |
5.449600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.12950000003198E-06 |
| Normal-vs-AfricanAmerican |
1.199030E-03 |
| Normal-vs-Asian |
8.839200E-01 |
| Caucasian-vs-AfricanAmerican |
7.170000E-01 |
| Caucasian-vs-Asian |
3.078300E-02 |
| AfricanAmerican-vs-Asian |
8.575800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.78010000000595E-05 |
| Normal-vs-Female |
3.66510000000542E-05 |
| Male-vs-Female |
9.038000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.600600E-04 |
| Normal-vs-Age(41-60Yrs) |
1.392780E-04 |
| Normal-vs-Age(61-80Yrs) |
3.53980000000753E-05 |
| Normal-vs-Age(81-100Yrs) |
3.321700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.240400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.831400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.628400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.014400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.912200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.678800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.883000E-03 |
| Normal-vs-Grade 2 |
3.86359999993147E-07 |
| Normal-vs-Grade 3 |
1.841870E-03 |
| Normal-vs-Grade 4 |
1.390440E-02 |
| Grade 1-vs-Grade 2 |
8.747000E-01 |
| Grade 1-vs-Grade 3 |
1.488820E-01 |
| Grade 1-vs-Grade 4 |
4.506400E-01 |
| Grade 2-vs-Grade 3 |
1.499980E-03 |
| Grade 2-vs-Grade 4 |
2.268400E-01 |
| Grade 3-vs-Grade 4 |
4.723000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.95360000002187E-06 |
| Normal-vs-ccB subtype |
9.413000E-04 |
| ccA subtype-vs-ccB subtype |
3.871200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.212780E-04 |
| Normal-vs-N1 |
1.499370E-01 |
| N0-vs-N1 |
6.663200E-01 |
|
|
